Repligen Corp.
(NASDAQ : RGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-1.02%291.131.4%$880.00m
AMGNAmgen, Inc.
1.71%224.471.3%$497.26m
CELGCelgene Corp.
0.74%110.391.3%$450.04m
GILDGilead Sciences, Inc.
-0.26%64.471.0%$390.95m
ILMNIllumina, Inc.
0.96%297.833.5%$313.62m
VRTXVertex Pharmaceuticals, Inc.
1.23%204.381.9%$295.67m
REGNRegeneron Pharmaceuticals, Inc.
1.02%347.792.6%$259.18m
EXASEXACT Sciences Corp.
-0.14%80.4224.0%$200.59m
ALXNAlexion Pharmaceuticals, Inc.
0.57%109.632.0%$192.74m
SGENSeattle Genetics, Inc.
0.87%109.246.1%$125.11m
BMRNBioMarin Pharmaceutical, Inc.
1.53%76.484.3%$109.17m
AAgilent Technologies, Inc.
0.44%77.191.6%$101.32m
SRPTSarepta Therapeutics, Inc.
3.62%98.2114.6%$96.74m
MRTXMirati Therapeutics, Inc.
2.69%105.952.3%$93.42m
NBIXNeurocrine Biosciences, Inc.
1.04%112.005.0%$83.89m

Company Profile

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.